Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
6d35HAUGym95XjLe
Listen
